T1	CHEM 17 26	sevelamer
#1	AnnotatorNotes T1	C0718050; sevelamer; Organic Chemical · Pharmacologic Substance
T2	PROC 30 49	diálisis peritoneal
#2	AnnotatorNotes T2	C0031139; Peritoneal Dialysis; Therapeutic or Preventive Procedure
T3	PROC 632 640	se trató
#3	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	CHEM 68 77	sevelamer
#4	AnnotatorNotes T4	C0718050; sevelamer; Organic Chemical · Pharmacologic Substance
T5	CHEM 84 104	quelante del fósforo
T6	CHEM 133 141	aluminio
#5	AnnotatorNotes T6	C0002367; aluminum; Pharmacologic Substance · Element, Ion, or Isotope
T7	CHEM 143 149	calcio
#6	AnnotatorNotes T7	C0006675; calcium; Pharmacologic Substance · Biologically Active Substance · Element, Ion, or Isotope
T8	CHEM 153 158	bases
#7	AnnotatorNotes T8	C0178499; Base; Chemical Viewed Functionally
T9	CHEM 190 198	quelante
#8	AnnotatorNotes T9	C0007974; Chelating Agents; Pharmacologic Substance · Indicator, Reagent, or Diagnostic Aid
T10	PROC 220 239	diálisis peritoneal
#9	AnnotatorNotes T10	C0031139; Peritoneal Dialysis; Therapeutic or Preventive Procedure
T11	PROC 341 352	tratamiento
#10	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	CHEM 399 420	quelantes del fósforo
T13	PROC 424 443	diálisis peritoneal
#11	AnnotatorNotes T13	C0031139; Peritoneal Dialysis; Therapeutic or Preventive Procedure
T14	PROC 488 507	diálisis peritoneal
#12	AnnotatorNotes T14	C0031139; Peritoneal Dialysis; Therapeutic or Preventive Procedure
T15	CHEM 521 542	hidróxido de aluminio
#13	AnnotatorNotes T15	C0002371; aluminum hydroxide; Pharmacologic Substance · Inorganic Chemical
T16	CHEM 558 573	sales de calcio
#14	AnnotatorNotes T16	C0357197; calcium salts; Pharmacologic Substance · Inorganic Chemical
T17	DISO 599 611	hipocalcemia
#15	AnnotatorNotes T17	C0020598; Hypocalcemia; Disease or Syndrome
T18	CHEM 645 654	sevelamer
#16	AnnotatorNotes T18	C0718050; sevelamer; Organic Chemical · Pharmacologic Substance
T19	PROC 698 709	tratamiento
#17	AnnotatorNotes T19	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T20	CHEM 744 753	sevelamer
#18	AnnotatorNotes T20	C0718050; sevelamer; Organic Chemical · Pharmacologic Substance
T21	CHEM 873 894	hidróxido de aluminio
#19	AnnotatorNotes T21	C0002371; aluminum hydroxide; Pharmacologic Substance · Inorganic Chemical
T22	CHEM 929 944	sales de calcio
#20	AnnotatorNotes T22	C0357197; calcium salts; Pharmacologic Substance · Inorganic Chemical
T23	PROC 1005 1027	producto calciofósforo
#21	AnnotatorNotes T23	C3641229; Calcium and Phosphorus Product Measurement; Laboratory Procedure
T24	PROC 1337 1341	GGTY
#22	AnnotatorNotes T24	C0202035; Gamma glutamyl transferase measurement; Laboratory Procedure
T25	CHEM 1194 1197	CO2
#23	AnnotatorNotes T25	C0007012; carbon dioxide; Biologically Active Substance · Inorganic Chemical
T26	CHEM 1386 1410	1,25 dihidroxivitamina D
#24	AnnotatorNotes T26	C0006674; calcitriol; Organic Chemical · Pharmacologic Substance · Vitamin | C0370232; 1,25-dihydroxyvitamin D; Organic Chemical · Vitamin
T27	PROC 1244 1262	fosfatasa alcalina
#25	AnnotatorNotes T27	C0201850; Alkaline phosphatase measurement; Laboratory Procedure
T28	PROC 1370 1381	tratamiento
#26	AnnotatorNotes T28	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T29	PROC 1430 1449	diálisis peritoneal
#27	AnnotatorNotes T29	C0031139; Peritoneal Dialysis; Therapeutic or Preventive Procedure
T30	CHEM 1453 1462	sevelamer
#28	AnnotatorNotes T30	C0718050; sevelamer; Organic Chemical · Pharmacologic Substance
T31	CHEM 1536 1551	sales de calcio
#29	AnnotatorNotes T31	C0357197; calcium salts; Pharmacologic Substance · Inorganic Chemical
T32	PROC 1497 1507	fosforemia
#30	AnnotatorNotes T32	C0853172; Blood phosphorus; Laboratory Procedure
T33	Route 39 49	peritoneal
#31	AnnotatorNotes T33	C1706534; Peritoneal dialysis route; Functional Concept
T34	PROC 248 264	práctica clínica
T35	PROC 376 386	fosforemia
#32	AnnotatorNotes T35	C0853172; Blood phosphorus; Laboratory Procedure
T36	DISO 616 631	hiperfosforemia
#33	AnnotatorNotes T36	C0919625; Blood phosphorus increased; Finding
T37	Route 229 239	peritoneal
#34	AnnotatorNotes T37	C1706534; Peritoneal dialysis route; Functional Concept
T38	CHEM 357 366	sevelamer
#35	AnnotatorNotes T38	C0718050; sevelamer; Organic Chemical · Pharmacologic Substance
T39	Route 433 443	peritoneal
#36	AnnotatorNotes T39	C1706534; Peritoneal dialysis route; Functional Concept
T40	Route 497 507	peritoneal
#37	AnnotatorNotes T40	C1706534; Peritoneal dialysis route; Functional Concept
T41	PROC 949 959	fosforemia
#38	AnnotatorNotes T41	C0853172; Blood phosphorus; Laboratory Procedure
T42	PROC 1078 1088	colesterol
#39	AnnotatorNotes T42	C0201950; Cholesterol measurement test; Laboratory Procedure
T43	PROC 1179 1192	triglicéridos
#40	AnnotatorNotes T43	C0202236; Triglycerides measurement; Laboratory Procedure
T44	PROC 1194 1203	CO2 total
#41	AnnotatorNotes T44	C0201930; Carbon dioxide content measurement; Laboratory Procedure
T45	PROC 1210 1213	PTH
#42	AnnotatorNotes T45	C0202159; Parathyroid hormone measurement; Laboratory Procedure
T46	Route 1439 1449	peritoneal
#43	AnnotatorNotes T46	C1706534; Peritoneal dialysis route; Functional Concept
T47	CHEM 1557 1565	aluminio
#44	AnnotatorNotes T47	C0002367; aluminum; Pharmacologic Substance · Element, Ion, or Isotope
T48	PROC 1579 1602	producto calcio-fósforo
#45	AnnotatorNotes T48	C3641229; Calcium and Phosphorus Product Measurement; Laboratory Procedure
T51	Neg_cue 123 125	no
T52	Neg_cue 150 152	ni
T54	Frequency 265 271	diaria
T56	LIVB 462 471	pacientes
#46	AnnotatorNotes T56	C0030705; Patients; Patient or Disabled Group
T58	Neg_cue 574 577	sin
T59	LIVB 664 673	pacientes
#47	AnnotatorNotes T59	C0030705; Patients; Patient or Disabled Group
T60	Duration 686 694	12 meses
T61	Dose 761 775	2.280 ± 760 mg
T62	Frequency 775 779	/día
T63	Dose 795 811	dos o tres dosis
T64	Duration 816 828	los 12 meses
T65	Dose 833 849	2.760 ± 1.160 mg
T66	Frequency 849 853	/día
T67	Duration 857 869	los 12 meses
T72	Duration 1265 1276	los 6 meses
T73	Duration 1305 1317	los 12 meses
T75	LIVB 1349 1358	pacientes
#48	AnnotatorNotes T75	C0030705; Patients; Patient or Disabled Group
T49	PROC 904 914	suspendido
#49	AnnotatorNotes T49	C0850893; stop medication; Therapeutic or Preventive Procedure
A1	Assertion T6 Negated
A2	Assertion T7 Negated
A3	Assertion T8 Negated
A4	Assertion T17 Negated
#50	AnnotatorNotes T5	C4020599; Phosphate Binders; Pharmacologic Substance
#51	AnnotatorNotes T12	C4020599; Phosphate Binders; Pharmacologic Substance
R1	Negation Arg1:T58 Arg2:T17	
T50	Neg_cue 1319 1322	sin
T53	CONC 1323 1330	cambios
A5	Assertion T53 Negated
#52	AnnotatorNotes T53	C0443172; Changed status; Quantitative Concept
R2	Negation Arg1:T50 Arg2:T53	
T55	CONC 1149 1156	cambios
A6	Assertion T55 Negated
#53	AnnotatorNotes T55	C0443172; Changed status; Quantitative Concept
T57	Neg_cue 1141 1143	No
R3	Negation Arg1:T57 Arg2:T55	
R4	Negation Arg1:T51 Arg2:T6	
R5	Negation Arg1:T51 Arg2:T7	
R6	Negation Arg1:T52 Arg2:T8	
T68	Quantifier_or_Qualifier 108 118	absorbible
A7	Assertion T68 Negated
#54	AnnotatorNotes T68	C2699518; Absorbable; Qualitative Concept
R7	Has_Quantifier_or_Qualifier Arg1:T5 Arg2:T68	
T69	Neg_cue 105 107	no
R8	Negation Arg1:T69 Arg2:T68	
R9	Used_for Arg1:T1 Arg2:T2	
R10	Has_Route_or_Mode Arg1:T2 Arg2:T33	
R11	Used_for Arg1:T9 Arg2:T10	
R12	Has_Route_or_Mode Arg1:T10 Arg2:T37	
R13	Overlap Arg1:T34 Arg2:T54	
R14	Used_for Arg1:T38 Arg2:T11	
R16	Has_Route_or_Mode Arg1:T13 Arg2:T39	
R17	Used_for Arg1:T12 Arg2:T13	
R18	Has_Route_or_Mode Arg1:T14 Arg2:T40	
R19	Experiences Arg1:T56 Arg2:T14	
R20	Experiences Arg1:T56 Arg2:T15	
R21	Experiences Arg1:T56 Arg2:T16	
R22	Experiences Arg1:T56 Arg2:T17	
R23	Experiences Arg1:T56 Arg2:T36	
R24	Used_for Arg1:T18 Arg2:T3	
R25	Experiences Arg1:T56 Arg2:T3	
R27	Overlap Arg1:T14 Arg2:T3	
R28	Experiences Arg1:T59 Arg2:T19	
R29	Has_Duration_or_Interval Arg1:T19 Arg2:T60	
T70	Observation 674 685;698 709	completaron tratamiento
#55	AnnotatorNotes T70	C0580352; Treatment completed; Finding
R31	Overlap Arg1:T70 Arg2:T60	
R32	Has_Dose_or_Strength Arg1:T20 Arg2:T61	
R33	Has_Frequency Arg1:T20 Arg2:T62	
R34	Has_Dose_or_Strength Arg1:T20 Arg2:T63	
R35	Has_Dose_or_Strength Arg1:T20 Arg2:T65	
R36	Has_Duration_or_Interval Arg1:T20 Arg2:T64	
R37	Has_Frequency Arg1:T20 Arg2:T66	
R38	Used_for Arg1:T21 Arg2:T49	
R39	Overlap Arg1:T49 Arg2:T67	
R40	Used_for Arg1:T22 Arg2:T49	
R41	Overlap Arg1:T41 Arg2:T67	
R42	Overlap Arg1:T23 Arg2:T67	
R43	Overlap Arg1:T42 Arg2:T67	
T71	Observation 1078 1088;1127 1139	colesterol disminuyeron
#56	AnnotatorNotes T71	C4313076; Decreased cholesterol; Finding
R44	Overlap Arg1:T71 Arg2:T67	
T74	Observation 1127 1139;949 959	disminuyeron fosforemia
#57	AnnotatorNotes T74	C0877517; Blood phosphorus decreased; Finding
T76	Observation 1005 1027;1127 1139	producto calciofósforo disminuyeron
R45	Overlap Arg1:T76 Arg2:T67	
T77	Observation 1230 1262	aumento de la fosfatasa alcalina
#58	AnnotatorNotes T77	C0151849; Alkaline phosphatase raised; Finding
R50	Overlap Arg1:T77 Arg2:T72	
T78	Observation 1244 1262;1291 1302	fosfatasa alcalina normalizado
#59	AnnotatorNotes T78	C0858306; Alkaline phosphatase normal; Finding
R52	Overlap Arg1:T78 Arg2:T73	
R54	Overlap Arg1:T24 Arg2:T73	
R55	Experiences Arg1:T75 Arg2:T28	
R56	Used_for Arg1:T26 Arg2:T28	
R57	Has_Route_or_Mode Arg1:T29 Arg2:T46	
R58	Used_for Arg1:T30 Arg2:T29	
R59	Overlap Arg1:T11 Arg2:T12	
R62	Overlap Arg1:T27 Arg2:T72	
R51	Overlap Arg1:T27 Arg2:T73	
R63	Overlap Arg1:T24 Arg2:T72	
R64	Overlap Arg1:T29 Arg2:T32	
R65	Before Arg1:T30 Arg2:T32	
R67	Overlap Arg1:T29 Arg2:T31	
R68	Overlap Arg1:T29 Arg2:T47	
R69	Before Arg1:T30 Arg2:T48	
R70	Overlap Arg1:T30 Arg2:T31	
R71	Overlap Arg1:T30 Arg2:T47	
T79	Quantifier_or_Qualifier 1157 1171	significativos
A8	Assertion T79 Negated
#60	AnnotatorNotes T79	C0750502; Significant; Idea or Concept
R72	Has_Quantifier_or_Qualifier Arg1:T55 Arg2:T79	
R73	Negation Arg1:T57 Arg2:T79	
A9	Experiencer T56 Patient
A10	Experiencer T59 Patient
A11	Experiencer T75 Patient
R15	Has_Result_or_Value Arg1:T41 Arg2:T74	
R26	Has_Result_or_Value Arg1:T23 Arg2:T76	
R30	Has_Result_or_Value Arg1:T42 Arg2:T71	
R46	Has_Result_or_Value Arg1:T27 Arg2:T78	
R47	Has_Result_or_Value Arg1:T27 Arg2:T77	
